Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1097/JCMA.0000000000000338 http://scihub22266oqcxt.onion/10.1097/JCMA.0000000000000338 32349031!7493766!32349031     free     free     free Deprecated: Implicit conversion from float 219.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 219.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 219.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 219.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 219.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       J+Chin+Med+Assoc 2020 ; 83 (8): 710-711 Nephropedia Template TP {{tp|p=32349031|t=2020. Role of dipeptidyl peptidase-4 inhibitors in patients with diabetes infected with coronavirus-19 |pdf=|usr=}}{{32349031}} gab.com Text Role of dipeptidyl peptidase-4 inhibitors in patients with diabetes infected with coronavirus-19 JO: J Chin Med Assoc http://www.kidney.de/pget.php?&tw=1&pmid=32349031 #FOAvip The pandemic infection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is widely increasing the patients affiliated with coronavirus disease 2019 (COVID-19) from last December of 2019. It is reported that the entry receptor of SARS-CoV-2 has been confirmed to be angiotensin-converting enzyme 2 (ACE2). Notably, whether the ACE-related inhibitors or drugs modulated ACE2 activity in affecting the viral activity and disease severity of SARS-CoV-2 is still an open question. Dipeptidyl peptidase-4 (DDP-4), a well-known anti-diabetic drug, has been widely used to control the glycemic condition in patients with diabetes. In this article, we are focusing on the impact of ACE inhibitors (ACEI) and DPP4 inhibitors used on SARS-CoV-2 activity and discussions about those drugs that may be related to infectious condition of COVID-19 diseases. Twit Text FOAVip Role of dipeptidyl peptidase-4 inhibitors in patients with diabetes infected with coronavirus-19 ????J Chin Med Assoc http://www.kidney.de/pget.php?&tw=1&pmid=32349031 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32349031 #FOAvip English Wikipedia <ref>{{Cite pmid|32349031}}</ref> Role of dipeptidyl peptidase-4 inhibitors in patients with diabetes infected with coronavirus-19 #MMPMID32349031 Chen CF; Chien CH; Yang YP; Chou SJ; Wang ML; Huo TI; Lin CC J Chin Med Assoc 2020[Aug]; 83 (8): 710-711 PMID32349031show ga The pandemic infection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is widely increasing the patients affiliated with coronavirus disease 2019 (COVID-19) from last December of 2019. It is reported that the entry receptor of SARS-CoV-2 has been confirmed to be angiotensin-converting enzyme 2 (ACE2). Notably, whether the ACE-related inhibitors or drugs modulated ACE2 activity in affecting the viral activity and disease severity of SARS-CoV-2 is still an open question. Dipeptidyl peptidase-4 (DDP-4), a well-known anti-diabetic drug, has been widely used to control the glycemic condition in patients with diabetes. In this article, we are focusing on the impact of ACE inhibitors (ACEI) and DPP4 inhibitors used on SARS-CoV-2 activity and discussions about those drugs that may be related to infectious condition of COVID-19 diseases. |Angiotensin-Converting Enzyme Inhibitors/pharmacology[MESH] |Betacoronavirus/*drug effects[MESH] |COVID-19[MESH] |Coronavirus Infections/*etiology[MESH] |Diabetes Mellitus/*drug therapy[MESH] |Dipeptidyl-Peptidase IV Inhibitors/*pharmacology[MESH] |Humans[MESH] |Pandemics[MESH] |Pneumonia, Viral/*etiology[MESH]Role of dipeptidyl peptidase-4 inhibitors in patients with diabetes in(epmc).pdf DeepDyve Pubget Overpricing